Cefdinir Powder, For Suspension
Product Images NDC 63187-835

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 63187-835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-835-00 (Cefdinir Fig1)

This is a description for Cefdinir, an oral suspension medication with a dosage of 125mg/5mL, manufactured by Aurobindo Pharma Limited in Hyderabad, India. The product is packaged in a 100 mL bottle with an expiration date of 00/00/00 and an NDC number of 63187-835-00. The suspension must be reconstituted before use, and each 5 mL contains 125mg of cefdinir USP. Storage conditions are specified to be between 20°-25°C (68°-77°F), and the medication should be kept out of reach of children.*

FDA Label Image

Chemical Structure (Cefdinir Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.